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Homozygosity mapping is a very powerful method
for finding rare recessive disease genes in mono-
genic disorders and may also be useful for locating
risk genes in complex disorders, late onset dis-
orders where parents often are not available, and
for rare phenotypic subgroups. In the present
study, homozygosity mapping was applied to 24
persons with bipolar disorder from 22 inbred
families. The families were selected irrespective
of whether other affected family members were
present or not. A genome wide screen using geno-
types from only a single affected person in each
family was performed using the AFFYMETRIX
GeneChip HuSNP Mapping Assay, which contains
1,494 single nucleotide polymorphisms. At chro-
mosome 17q24-q25 a parametric multipoint LOD
score of 1.96 was found at WIAF-2407 and WIAF-
2405. When analyzing 19 additional microsatellite
markers on chromosome 17q the maximum para-
metric multipoint LOD score was 2.08, 1.5 cM
proximal to D17S668. The present study replicates
a recent significant linkage finding.
 2005 Wiley-Liss, Inc.
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INTRODUCTION
Bipolar disorder is a severe psychiatric disorder with a
lifetime prevalence of 0.3–1.5%. Though most individuals with
bipolar disorder do not have affected first-degree relatives, the
high concordance ratio for mono- and dizygotic twins suggest
that genetic factors are of importance. Bipolar disorder is a
complex disorder in which rare, large families with multiple
affected individuals do occur. It is possible that the inheritance
in such families is monogenic or at least oligogenic. Most
studies of bipolar disorder have applied parametric or non-
parametric linkage analyses to larger families and a number of
chromosome regions potentially containing risk genes have
been identified [Baron, 2002].
Homozygosity mapping as a method for identifying chromo-
some regions harboring disease genes for rare recessive dis-
eases was originally suggested by Lander and Botstein [1987].
The basic principle of homozygosity mapping is that an affected
person has inherited two identical copies of the disease gene
from a common ancestor. In consanguineous families, patients
with rare recessive diseases are likely to be homozygous by
descent (HBD) for the disease allele and nearby markers. This
method has almost exclusively been applied to rare recessive
diseases in patients whose parents are first or second cousins
[e.g., Wang et al., 2001]. The average size of a segment, which is
HBD surrounding a rare recessive disease gene, is on average
33.3, 25, and 20 cM, respectively, for a single affected offspring
of first, second, or third cousins [Wright et al., 1997]. Offspring
of first cousins are on average HBD on 1/16 of their genome,
while offspring of second or third cousins are on average HBD
on 1/64 and 1/256 of their genome, respectively. The disease
gene for a rare recessive disease has been identified by initially
searching for homozygous segments among more distantly re-
lated cases from isolated populations, with incomplete knowl-
edge about their genealogy [Houwen et al., 1994; Bull et al.,
1998, 1999]. It has been suggested to apply homozygosity
mapping on complex disorders [Miano et al., 2000]. However,
to our knowledge, this method has only been applied to an
apparently recessive subform of early-onset Parkinsonism
[van Duijn et al., 2001], and a single inbred pedigree with
several siblings with bipolar disorder [Ewald et al., 2003].
Homozygosity mapping is a very powerful method when
applying parametric, recessive LOD score analyses as one
affected offspring of parents who are first cousins may yield a
LOD score around 1.2 for a rare, fully penetrant, recessive
disease (Table I).
In inbred families with more than one affected offspring,
parametric as well as non-parametric linkage analyses can be
applied [Ewald et al., 2003; Modin et al., 2003]. It has not yet
been attempted to apply homozygosity mapping on families
with a possibly more complex inheritance pattern with only a
single affected offspring. Recessive risk alleles may be present
in complex disorders such as bipolar disorder. Furthermore,
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‘‘sporadic’’ cases without known affected close relatives are
compatible with recessive risk alleles.
The present study searched for homozygous chromosome
regions among 24 cases with bipolar disorder whose parents
were third cousins or more closely related. A genome wide scan
was performed, using the AFFYMETRIX GeneChip HuSNP
Mapping Assay with 1,494 single nucleotide polymorphisms
(SNPs).
MATERIALS AND METHODS
Collection of Cases, Controls,
and Diagnostic Assessment
Well-documented cases with severe bipolar disorder were
sought among in- or out-patients, who originated from a
specific subregion around the city of Velasco, in the Holguı´n
region in Eastern Cuba. The majority of the inhabitants in the
region are of Caucasian descent, while a smaller minority is of
Afro-American descent. The population size of the Velasco
region is today around 44,000, and there has been a tradition
for marriages between cousins and previously an average of
nine children per marriage.
In order to be included the cases had to be Caucasian, of
European descent and their parents had to be related, pre-
ferably as first or second cousins (Fig. 1). Cases were collected
irrespective of their age of onset of bipolar disorder and the
presence or absence of other affected family members. Some of
the cases were close relatives. The affected persons in F3V1
and F3V2 were parent and child who were inbred through
partly different loops (not shown in Fig. 1). F4V2 and F4V3
were siblings and F19V10 and F19V16 were siblings. F19V9
and the siblings F19V10–V16 were third degree relatives.
Some of the other cases were more distantly related. Further-
more F3V1 and F3V2 were related to F3V9 (second degree
relative of F3V1), and more distantly to F3V30. F3V18 and
F3V32 were first cousins. At present, no first-degree relatives
of cases in families F2V1, F3V9, F3V30, F7V1, F22V1, and
F26V1 have affective disorder.
After obtaining informed consent the patients were inter-
viewed by an experienced psychiatrist Dr. Mario Torralba,
Holguı´n, Cuba, using the full Spanish language version 2.1 of
the SCAN [Wing et al., 1990]. Based on the interview and
hospital case notes, a clinical narrative was made for each
patient. The final diagnosis was made as a consensus best-
estimate diagnosis by two experienced psychiatrists Dr. O. Mors
and Dr. A. Bertelsen, Aarhus, Denmark, who independently
reviewed the clinical narrative and if necessary other relevant
material. The diagnoses were made in accordance with ICD-10,
Diagnostic Criteria for Research [World Health Organization,
1993], and the fourth edition of the Diagnostic and Statistical
Manual (DSM-IV) [American Psychiatric Association, 1994].
All 24 included patients had bipolar affective disorder accord-
ing to ICD-10 and bipolar type 1 disorder according to DSM-IV.
The range of age of onset of affective disorder was 9–50 years.
Seventeen of the 24 cases were women. Controls with similar
age as the cases and without known history of psychiatric dis-
eases were selected randomly among residents from the
Velasco region. Of the 54 included controls 27 were men.
Genotyping
The AFFYMETRIX GeneChip HuSNP Mapping Assay,
with 1,494 SNPs distributed on the 22 autosomes and the
X chromosome was applied for the 24 cases and 54 controls.
DNA was assayed and scanned according to the HuSNP
protocol supplied by AFFYMETRIX, Inc., Santa Clara, CA, as
described previously [Primdahl et al., 2002].
SNPs were positioned for genetic mapping using the SNP
database at NCBI, build 101, (based on genome assembly build
27 (http://www.ncbi.nlm.nih.gov/SNP/)). SNPs with ambigu-
ous positions were excluded, except where the differences in
position did not influence the order of the markers. Additional
sixteen positioned on the X chromosome, were excluded from
the analyses because all families except families F12, F19,
and F27, had transmission from father to son. Based on this
strategy a total of 1,168 SNP markers were analyzed.
The 54 controls were used for estimating allele frequencies.
However, if any specific SNP was unambiguously genotyped on
less than 60 out of the 108 control chromosomes, the frequency
obtained from AFFYMETRIX was used. These allele frequen-
cies are generated from 133 unrelated individuals, 113 of
Western European descent, ten African-Americans and ten of
Asian descent. If an allele was not observed among any of the
108 control chromosomes its frequency was set to 1/108
(0.0093).
The average distance between the SNPs is approximately
3 cM, which should be sufficient to detect most HBD regions in
affected offspring from first, second, or third cousins. The SNP
heterozygosity of the 133 control persons tested by AFFYME-
TRIX has a median of 36% (25th and 75th percentile of 22 and
47%, respectively). The informativity of two to three SNPs
corresponds roughly to one microsatellite marker [Kruglyak,
1997].
Thirteen additional SNPs were genotyped in regions where
the distance between neighboring SNPs was greater than
15 Mb. In addition ten randomly chosen SNPs, which were in
Hardy–Weinberg equilibrium and not associated with the
disorder, were regenotyped in order to evaluate genotyping
error frequencies. These 23 SNPs were amplified using touch-
down PCR. Excess primers and dNTPs were degraded using
shrimp alkaline phosphatase (SAP) (USB) and exonuclease I
(USB). The SNPs was analyzed by a primer extension reaction
according to the SNaPshot protocol (Applied Biosystems,
Foster City, CA). Excess labeled nucleotides were degraded
and reaction products were analyzed on an ABI 3100 auto-
mated sequencer (Applied Biosystems).
Microsatellite markers were amplified using a Perkin-Elmer
9700 thermocycler and were subsequently analyzed on an ABI
Prism 3100 or 310 Genetic Analyzer (Applied Biosystems).
Specific PCR conditions, when available, from http://www-
gdb.cmbi.kun.nl/gdb/ were further optimized for multiplex
PCR.
TABLE I. Parametric LOD Scores Assuming a Recessive Mode
of Inheritance Modeled as a Monogenic Disease (Penetrances 0, 0,
and 1, Disease Allele Frequency 0.001) or a Complex
Disease (Penetrances 0.005, 0.005, and 0.65,
Disease Allele Frequency 0.10)
Parents 1st
cousins
Parents 2nd
cousins
Parents 3rd
cousins
Monogenic
0.1 0.80 (1.29) 0.92 0.90
0.01 1.14 (1.72) 1.57 1.76
0.001 1.19 (1.79) 1.75 2.21
Complex
0.1 0.36 (0.85) 0.20 0.07
0.01 0.61 (1.21) 0.58 0.38
0.001 0.66 (1.27) 0.73 0.69
0.0001 0.66 (1.28) 0.75 0.77
A single affected offspring is genotyped and homozygous for a single marker
with frequency of the relevant marker allele of 0.1, 0.01, 0.001, or 0.0001 as
shown above. For two affected siblings that are homozygous for the same
marker with 1st cousin parents the LOD score is shown in parentheses.
The other family members have been coded as being phenotype unknown.
The LOD score at zero recombination frequency is shown.
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Statistical Analysis
A number of different analyses were performed in order to
search for homozygous segments. Multipoint and single point
parametric LOD scores were calculated for the autosomal
markers with known physical order, using GENEHUNTER
version 2.0 [Kruglyak et al., 1996]. This was done using a
recessive model, and performing an affected-only analysis.
Bipolar disorder is a complex disease and penetrances were
therefore set to 0.005, 0.005, and 0.65 for carriers of none, one
and two disease alleles, respectively. The disease allele
frequency was set to 0.1 as in previous studies [Ewald et al.,
2002]. A 1 Mb physical distance between SNPs was roughly
transformed to a 1 cM genetic distance. SNPs closer than
10.000 base pairs were set to a distance of 0.0001. The maxi-
mum obtainable LOD score for a single affected offspring being
homozygous for a marker allele depends on the relatedness of
the parents, the penetrances, and marker and disease allele
frequencies. In order to evaluate power, two-point LOD scores
for a monogenic or a complex recessive disease were calculated
using GENEHUNTER with the parameters specified (Table I).
A total LOD score of above 3 may be obtained if five unrelated
affected persons, whose parents are first cousins, are homozyg-
ous for an allele or haplotype with a frequency of 0.01 or less.
RESULTS
Single- and multipoint parametric LOD scores above 1.0 are
shown in Table II. High single point LOD scores at WIAF-3227
on chromosome 14 and at WIAF-1706 on chromosome 22 were
found to be errors upon regenotyping. These SNPs were ex-
cluded from the multipoint analysis.
The highest LOD score found was a multipoint LOD score of
1.96 distally on chromosome 17q25 for the two neighboring
markers WIAF-2407 and WIAF-2405. On chromosome 10, a
multipoint LOD score of 1.24 was found at WIAF-4519 in a very
broad region with 25 neighboring markers yielding positive
multipoint LOD scores. A multipoint LOD score of 1.19 was
found at WIAF-1969 on chromosome 20q in a region with nine
neighboring markers yielding positive multipoint LOD scores.
On chromosome 11p, a peak multipoint LOD score of 1.13 at
WIAF-3023 was found in a region with 15 neighboring markers
all with positive multipoint LOD scores.
The highest single point LOD score was 1.26 at WIAF-1805
on chromosome 12p (Table II). In this region nine neighboring
markers yielded positive multipoint LOD scores with a
maximum of 0.67 at WIAF-3049. No positive multipoint LOD
scores or single point LOD scores above 0.15 were found
distally on chromosome 8q, suggesting that the single point
Fig. 1. The inbred families with the affected offspring shown as filled symbols. Sex has been disguised in order to ensure confidentiality.
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LOD score of 1.26 at WIAF-583 in this region was a chance
finding. In the region on chromosome 17q25 suggested by
multipoint LOD scores, WIAF-2858 yielded a single point LOD
score of 1.18. In this region eight of the ten most distal markers
yielded positive single point LOD scores. On chromosome 10p,
WIAF-3130 yielded a LOD score of 1.10, however, the neigh-
boring markers yielded single point LOD scores close to zero.
WIAF-303 on chromosome 10 yielded a LOD score of 1.05.
Nearby markers yielded negative single point LOD scores.
WIAF-786 on chromosome 19 yielded a LOD score of 1.04,
but was only weakly supported by LOD scores from other
neighboring markers and all multipoint LOD scores in the
region were negative. Finally, a single point LOD score of 1.04
at WIAF-2137 on chromosome 18p received support from a
number of nearby markers.
In individual families the highest LOD scores were 1.25 at
WIAF-2303 for the affected sib-pair F19V10–V16 at chromo-
some 10q23.31, 1.17 at WIAF-3130 for sib-pair F4V2–V3 at
chromosome 10p and 1.02 at WIAF-3310 for sib-pair F19V10–
V16 at chromosome 9q34.2.
Concerning the ten randomly chosen SNPs, that were
regenotyped several times, eight markers produced consistent
and identical results, for one marker a single genotyping was
discrepant, while a single marker yielded very inconsistent
results. Considering all ten markers a total of 56 out of 706
genotypings were different (7.9%).
For further evaluation 19 microsatellite markers on 17q
(D17S1299-D17S928: 62–126.5 cM) were genotyped. Micro-
satellite markers usually are more informative than SNPs and
may further help to decide whether a given region is HBD or by
state.
The highest multipoint parametric LOD score was 2.08,
1.5 cM proximal to D17S668.
Positive LOD scores were seen for the seven most distal
microsatellite markers from D17S1847 at 111.2 cM to D17S928
at 126.5 cM. The highest single point LOD scores were 2.12 at
the most distal marker D17S928.
DISCUSSION
The present study is to our knowledge one of the first studies
which applies homozygosity mapping to a complex disorder
and one of the first linkage studies using microarrays. Using
GENEHUNTER it was possible to calculate multipoint param-
etric LOD scores including all markers in one analysis on
every autosome except chromosomes 1, 2, 6, and 8 on which
markers were subdivided into two segments. Combining all
families the highest parametric multipoint LOD scores were
found at chromosome 17q25, peaking at a LOD score of 1.96.
This finding was further supported by analyzing 19 micro-
satellites in the region, yielding a maximum multipoint para-
metric LOD score of 2.08 1.5 cM proximal to D17S668. The
region identified by the microsatellite markers was around
4 Mb and 20 cM more distal than the most significant SNP
markers, (WIAF-2407 and WIAF-2405) and around 3 Mb
and 14 cM more distal than the most distal SNP marker
(WIAF-3305) the distal neighbor of WIAF-2405. Additional
information was obtained when genotyping seven more telo-
meric microsatellite markers as the LOD score increased and
as the final region of most interest were found to be more distal.
A non-parametric significant LOD score of 3.63 between
bipolar disorder and D17S928 has recently been reported in a
sample of 250 pedigrees with bipolar disorder [Dick et al.,
2003]. D17S928 is located around 200,000 bp more distal than
our most interesting marker, D17S668. Our finding formally
replicates their finding. Bennet et al. [2002] investigated 154
affected sib-pairs from Ireland and United Kingdom and found
a LOD score (MLS) of 1.38 also peaking around D17S928.
Curtis et al. [2003] investigated seven larger pedigrees with
bipolar disorder and unipolar disorder from United Kingdom
and Iceland. Assuming a recessive mode of inheritance and
only including unipolar patients from bipolar families they
found a four-point LOD score of 1.9 at D17S939 at 105.7 cM,
i.e., proximal to the loci suggested by the other studies. This
region did not receive much support in a recent meta-analysis
of bipolar disorder [Segurado et al., 2003]. However, the meta-
analysis ranked findings from individual investigations and
the genome-wide scans included in the meta-analysis mainly
investigated larger pedigrees, which may preferentially harbor
dominant risk alleles. The finding of a common region on
chromosome 17q in four studies using different linkage anal-
ysis methods and different family material, ranging from
single affected individuals to large pedigrees from various
mainly Caucasian populations, is encouraging. The 17qter is
a gene rich region which contains a number of interesting
neurogenes.
Though the families were obtained from a specific subregion
in Cuba it is uncertain whether this is a founding population.
Around 700 inhabitants lived in the Holguı´n region in 1726
increasing to 12,695 in 1820. After 1817 more immigrants came
to the region, especially males from certain Canary Islands and
later from other regions of Spain. In 1862, the population had
TABLE II. Single- and Multipoint Parametric LOD Scores Above 1.0 Are Shown
LOD
score Marker No Chromosome
Multipoint 1.96 WIAF-2405 50, alpha¼1, marker 45 (WIAF-2450) to 51 (WIAF-3305)>1.50 17
LOD scores 1.24 WIAF-4519 24, alpha¼1, marker 21 (WIAF-1585) to 23 (WIAF-2438)>0.90 10
1.19 WIAF-1969 22, alpha¼1, marker 17 (WIAF-1648) to 24 (WIAF-3937)>0.81 20
1.13 WIAF-3492 15, alpha¼1, marker 13 (WIAF-4592) to 16 (WIAF-2313)>0.81 11
Single point 1.26 WIAF-1805 3 12
LOD scores 1.26 WIAF-583 80 8
1.18 WIAF-2858 48 17
1.10 WIAF-3130 2 10
1.05 WIAF-1805 12 10
1.04 WIAF-2857 10 19
1.04 WIAF-583 8 18
Multipoint 5.91 WIAF-2467 46, marker 44 (WIAF-364) to 47 (WIAF-2531) all >5.86 12
LOD scores 5.66 WIAF-3336 16, marker 15 (WIAF-3797) to 17 (WIAF-3901) all >5.53 10
Assuming 5.42 WIAF-3136 3, marker 2 (WIAF-3130) to marker 4 (WIAF-2158) all >5.40 10
Equal allele frequencies 5.33 WIAF-3684 23, marker 21 (WIAF-953) to 24 (WIAF-3937) all >4.64 20
Multipoint LOD scores above 5.3 with assumed allele frequencies of 0.5 for both marker alleles are shown. Only the maximum multipoint LOD score for
contiguous markers are shown. No is the marker number from pter. Alpha is the fraction of pedigrees linked.
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increased to 53,128. Today the size of the population is above
1 million. In a heterogenous population many different haplo-
types may harbor a risk locus in a specific region. This will also
decrease the power when applying homozygosity mapping as
many affected individuals will be heterozygous at neighboring
marker loci though they may be homozygous at the risk locus.
In each family multipoint LOD scores close to the maximum
obtainable (Table I) were identified in one or more chromosome
regions. This indicate that the density and informativity of
SNPs in general is sufficient to detect segments which are
inherited HBD, whether containing a disease allele or not,
through the specified genealogy. The affected sib-pairs in
families 4 and 19 yielded LOD scores on chromosome 10 close to
the maximum obtainable value (Table I). All offspring of
parents who are first cousins yielded from one to five regions
with LOD scores above 0.5, most of which were above 0.6. So
even when genotyping only one person, the affected offspring,
in each family the LOD scores were close to the maximum
obtainable value given the genetic parameters chosen (Table I).
Concerning LOD scores in families where the parents of cases
were more distantly related, more variable maximum LOD
scores were found ranging from a high LOD score of 0.66 in
family F3V9 (first and second cousins, Fig. 1) to no LOD scores
above 0.3 in family F9V2 (second cousins, Fig. 1). However, all
offspring of second cousins except F9V2 yielded LOD scores
above 0.4. The highest LOD score in F3V1, whose parents were
second and third cousins, was 0.34.
Our study indicates that it may be possible to identify regions
HBD by genotyping only a single offspring from first or second
cousins using microarrays with 1,100 or more SNPs. Cases
without affected first degree relatives also yielded regions with
high LOD scores, i.e., three, four, three, five, two, and zero
regions with a LOD score above 0.5 in families F2V1, F3V9,
F3V30, F7V1, F22V1, and F26V1, respectively. Therefore,
it seems reasonable also to apply homozygosity mapping to
‘‘sporadic’’ cases with bipolar disorder and probably also in
other complex disorders with high twin concordance ratios.
The genetic intermarker distances used in the calculations
are derived directly from the physical distances by translating
1 Mb to 1 cM. Even if these estimates are not correct, we feel
confident that the LOD scores are rather robust towards mis-
specification of genetic distances as the high density of SNPs
ensures detection of HBD regions.
False low LOD scores may be obtained by multipoint anal-
yses if the specified marker order is incorrect. We chose also to
perform single point analyses in order to diminish the risk of
missing interesting chromosome regions due to wrongly order-
ed markers.
By regenotyping ten SNPs, we found that a single of these
had a high error rate while the others were quite accurate. A
high error rate in individual markers may lead to false nega-
tive findings. However, as the average size of the homozygous
segments surrounding a recessive disease gene should be
around 25–30 cM, corresponding to eight to ten markers, such
segments might be identified by applying single point analyses
in addition to multipoint analyses. In addition, if a single
heterozygous marker is surrounded by a long homozygous
segment this may be a genotyping error which could be de-
tected by regenotyping. Concerning the direction of the errors
if the biallelic marker is in Hardy–Weinberg equilibrium, most
genotypes will be truly homozygous (except when both alleles
are of equal frequency). If the percentages of misclassified
genotypings are equal for homozygous and heterozygous geno-
typings, more homozygous genotypes will be wrongly classified
as heterozygous, than vice versa.
We suggest that homozygosity mapping might be applied for
finding recessive risk alleles in complex disorders. It may be
possible among offspring from first or second cousins and even
more distant related parents. It may also be useful for finding
risk genes in late onset disorders where parents are often not
available, for finding rare phenotypic subgroups, endopheno-
types or modifying genes in monogenic or complex diseases. If a
number of affected siblings could be investigated it may even be
applied in very heterogeneous disorders [Wright et al., 1997]. It
seems to be the only possible method for doing linkage analyses
on families with only one affected person. Sporadic cases are
more common than familial cases, and thus clinically very
important, in most complex disorders. In the future homo-
zygosity mapping of even distantly related cases may be faci-
litated by using microarrays with a very high density of SNPs.
Finally, the use of SNP microarray genotypings is a flexible
method to apply in genome scans as additional cases may be
included during the study.
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